Emzumab Omalizumab Injection

  • Medicine Name- Emzumab
  • API- Omalizumab
  • Packaging- 1 single-use vial
  • Strength- 150 mg
  • Manufactured by- Cipla
Get an Enquiry
Category:

Description

Healthcare professionals recommended Omalizumab is an anti-IgE antibody for:

  • Moderate to severe persistent asthma in patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids.
  • Chronic idiopathic urticaria in adults and adolescents 12 years of age and older who remain symptomatic despite H1 antihistamine treatment.

Dosage and Side Effects

For subcutaneous administration only. 

  • Divide doses of more than 150 mg among more than one injection site to limit injections to not more than 150 mg per site. 
  • Asthma: Administer Omalizumab 75-375 mg subcutaneously every 2 or 4 weeks. Determine dose and dosing frequency by serum total IgE level, measured before the start of treatment, and body weight. See the dose determination charts. 
  • Chronic Idiopathic Urticaria: Omalizumab 150 or 300 mg SC every 4 weeks. Dosing in CIU is not dependent on serum IgE level or body weight.

Asthma: The common side-effects of Omalizumab are arthralgia, pain, leg pain, fatigue, dizziness, fracture, arm pain, pruritus, dermatitis, and earache.

Chronic Idiopathic Urticaria: The common side-effects of Omalizumab include  nausea, nasopharyngitis, sinusitis, upper respiratory tract infection, viral upper respiratory tract infection, arthralgia, headache, and cough.

Warning and Precautions

  • Anaphylaxis: Administer only in a healthcare setting prepared to manage anaphylaxis that can be life-threatening and observe patients for an appropriate period of time after administration.
  • Malignancy: Malignancies have been observed in clinical studies. 
  • Acute Asthma Symptoms: Do not use it for the treatment of acute bronchospasm or status asthmaticus. 
  • Corticosteroid Reduction: Do not abruptly discontinue corticosteroids upon initiation of Omalizumab therapy.  
  • Fever, Arthralgia, and Rash: Stop Omalizumab if patients develop signs and symptoms similar to serum sickness. 
  • Eosinophilic Conditions: Be alert to eosinophilia, vasculitic rash, worsening pulmonary symptoms, cardiac complications, and/or neuropathy, especially upon reduction of oral corticosteroids.

FAQ's

Is omalizumab FDA approved?

Yes, the FDA approved Omalizumab in 2003 to treat asthma and idiopathic urticaria.

What is the cost of Omalizumab injection?

The cost of Omalizumab injection is affordable and one can readily purchase this medicine from any certified pharmaceutical supplier worldwide. 

What type of drug is Omalizumab?

The medicine Omalizumab is in a class of medications called monoclonal antibodies.

What is the procedure to buy Omalizumab from Indian Generic Medicines? 

Patients can simply fill out the order form or send mail to info@indiangenericmedicines.com. Patients can also send WhatsApp messages to +91 8130290915 or can dial the TOLL-FREE Number: 18008891064. We will reply ASAP with the details of the Omalizumab price as well as the procurement procedure.

Note:- The order will be confirmed only after the valid receipt of the prescription from the Physician.